In this study, senescence markers (such as P16INK4a), inflammatory macrophage phenotypes (CD86, CD163, MCP-1), and immunometabolic enzymes (SDH, ACLY) were evaluated as downstream mechanistic responses to DN rather than as diagnostic criteria for diabetes or DN themselves. This evidence concerns the gene CCL2 and liver dysplastic nodule.